A New Frontier
in the Understanding of Cardiac Arrhythmias

A Computer

Cardiac arrhythmias impact millions of people across the globe, increasing the risk of serious health-related issues,

including stroke, heart failure, and even death. Yet, the current standard of care — including antiarrhythmic drugs and blind, anatomical-based ablation therapy — is suboptimal and is associated with severe side effects and disappointingly low success rates.¹

There is a critical need for a safe and more effective ECG-based arrhythmia mapping system.

Vektor Medical, Inc. aims to revolutionize arrhythmia therapy with vMap™, a next generation, non-invasive system. Using the standard 12-lead ECG, vMap™ has been designed to provide physicians with actionable information  by visualizing potential arrhythmia hotspots in all four chambers of the heart.

Rapid
Non-Invasive
Workflow Optimized

100%

Vektor’s technology has been designed to provide physicians with information on arrhythmias in all four of the heart chambers.

¹ Saksena S, Slee A, Waldo AL et al. JACC 2011;58:1975-85; Verma et al. STAR-AF2 Trial (NEJM 2015)